136 related articles for article (PubMed ID: 32163390)
1. [miR-455 Inhibits HepG2 Cell Proliferation and Promotes Apoptosis by Targeting RhoC].
Xie SL; Wang M; Du XH; Zhao ZW; Lv GY
Mol Biol (Mosk); 2020; 54(1):69-77. PubMed ID: 32163390
[TBL] [Abstract][Full Text] [Related]
2. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-κB signaling pathway.
Wang RK; Shao XM; Yang JP; Yan HL; Shao Y
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2777-2785. PubMed ID: 31002128
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic miR-96-5p inhibits apoptosis by targeting the caspase-9 gene in hepatocellular carcinoma.
Iwai N; Yasui K; Tomie A; Gen Y; Terasaki K; Kitaichi T; Soda T; Yamada N; Dohi O; Seko Y; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Konishi H; Naito Y; Itoh Y
Int J Oncol; 2018 Jul; 53(1):237-245. PubMed ID: 29658604
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
8. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
9. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells.
Song L; Zhang W; Chang Z; Pan Y; Zong H; Fan Q; Wang L
Med Sci Monit; 2017 Apr; 23():1741-1750. PubMed ID: 28394882
[TBL] [Abstract][Full Text] [Related]
10. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
[TBL] [Abstract][Full Text] [Related]
11. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
12. miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3.
Wang M; Lv G; Jiang C; Xie S; Wang G
Sci Rep; 2019 Feb; 9(1):2032. PubMed ID: 30765768
[TBL] [Abstract][Full Text] [Related]
13. Effects of miR-489 targeting on SOX4 gene on proliferation and apoptosis of human hepatocellular carcinoma cells.
Wang B; Jin WX; Zhang YL; Huang L; Ni HB; Fang D
Afr Health Sci; 2020 Sep; 20(3):1292-1298. PubMed ID: 33402977
[TBL] [Abstract][Full Text] [Related]
14. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.
Zheng WW; Zhou J; Zhang CH; Liu XS
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
17. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC).
Gao B; Gao K; Li L; Huang Z; Lin L
Biomed Pharmacother; 2014 Mar; 68(2):143-8. PubMed ID: 24183204
[TBL] [Abstract][Full Text] [Related]
18. miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs.
Liao CG; Kong LM; Zhou P; Yang XL; Huang JG; Zhang HL; Lu N
J Transl Med; 2014 Sep; 12():234. PubMed ID: 25236186
[TBL] [Abstract][Full Text] [Related]
19. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
